WILMINGTON, Del. - The Official Committee of Unsecured Creditors in the Chapter 11 bankruptcy case of Savient Pharmaceuticals Inc. on Nov. 25 filed a brief in the U.S. Bankruptcy Court for the District of Delaware objecting to Savient's motion seeking approval to use cash collateral (In re: Savient Pharmaceuticals Inc., No. 13-12680, Chapter 11, D. Del. Bkcy.).